279 related articles for article (PubMed ID: 9264104)
1. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice.
De Sarro G; Chimirri A; McKernan R; Quirk K; Giusti P; De Sarro A
Pharmacol Biochem Behav; 1997 Sep; 58(1):281-9. PubMed ID: 9264104
[TBL] [Abstract][Full Text] [Related]
2. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
[TBL] [Abstract][Full Text] [Related]
3. 1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice.
De Sarro G; Gitto R; Rizzo M; Zappia M; De Sarro A
Gen Pharmacol; 1996 Sep; 27(6):935-41. PubMed ID: 8909973
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol- 3(3H)-ones in mice.
De Sarro G; Carotti A; Campagna F; Mckernan R; Rizzo M; Falconi U; Palluotto F; Giusti P; Rettore C; De Sarro A
Pharmacol Biochem Behav; 2000 Mar; 65(3):475-87. PubMed ID: 10683488
[TBL] [Abstract][Full Text] [Related]
5. Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines.
DeSarro GB; Zappalà M; Grasso S; Chimirri A; DeSarro A
Gen Pharmacol; 1993 Jul; 24(4):877-84. PubMed ID: 8224743
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
[TBL] [Abstract][Full Text] [Related]
7. GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
de Sarro G; Chimirri A; De Sarro A; Gitto R; Grasso S; Giusti P; Chapman AG
Eur J Pharmacol; 1995 Dec; 294(2-3):411-22. PubMed ID: 8750701
[TBL] [Abstract][Full Text] [Related]
8. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
10. Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.
Zanotti A; Mariot R; Contarino A; Lipartiti M; Giusti P
Br J Pharmacol; 1996 Feb; 117(4):647-52. PubMed ID: 8646409
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional effects of beta-carbolines in reflex epilepsy.
Chapman AG; De Sarro GB; Premachandra M; Meldrum BS
Brain Res Bull; 1987 Sep; 19(3):337-46. PubMed ID: 3119161
[TBL] [Abstract][Full Text] [Related]
13. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant actions of fominoben: possible involvement of benzodiazepine receptors.
Baldino F; Krespan B; Geller HM
Pharmacol Biochem Behav; 1984 Jul; 21(1):137-43. PubMed ID: 6087374
[TBL] [Abstract][Full Text] [Related]
15. Selective protection by adenosine receptor agonists against DMCM-induced seizures.
Petersen EN
Eur J Pharmacol; 1991 Mar; 195(2):261-5. PubMed ID: 1874275
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
17. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.
De Sarro G; Di Paola ED; Aguglia U; de Sarro A
Pharmacol Biochem Behav; 1996 Sep; 55(1):39-48. PubMed ID: 8870036
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice.
Croucher M; De Sarro G; Jensen L; Meldrum B
Eur J Pharmacol; 1984 Sep; 104(1-2):55-60. PubMed ID: 6499918
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine receptors studied in living primates by positron emission tomography: inverse agonist interactions.
Hantraye P; Chavoix C; Guibert B; Fukuda H; Brouillet E; Dodd RH; Prenant C; Crouzel M; Naquet R; Mazière M
Eur J Pharmacol; 1987 Jun; 138(2):239-47. PubMed ID: 3040433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
